Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(510)
•••
Comment by 2b7f6fabon Sep 20, 2017 6:49pm
106 Views
Post# 26722818

RE:RE:RE:RE:RE:Saving the new GBM data for after NMIBC new set of data???

RE:RE:RE:RE:RE:Saving the new GBM data for after NMIBC new set of data???Why would the patients have their bladders removed after they've been cured of the cancer?  You make no sense at all.

bionicjoe wrote:
2b7f6fab wrote: Actually these 3 were going to lose their life.  In order to participate in the trial they had to be unfit to have their bladder removed, or unwilling to have it removed.  The worst of the worst, Cured!

LaserStock29 wrote:
*And to think these three were on the brink of losing their bladder for LIFE doomed with a bag *

 

 


The patients have non muscle invasive baldder cancer not muscle invasive where the cancer threatens to spread to other parts of the body and is then considered lethal.

I think you have it wrong when you state the patients enrolled in this trial are unfit to have their bladders removed thus suggesting it's either try the TLT treatment or surely die. They in fact still have the option of having their bladder removed if the treatment doesn't work.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities